RadNet, Inc. (RDNT)

Market Cap	6.40B
Revenue (ttm)	1.97B
Net Income (ttm)	-12.71M
Shares Out	77.15M
EPS (ttm)	-0.17
PE Ratio	n/a
Forward PE	126.72
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,162,137
Open	79.26
Previous Close	79.26
Day's Range	78.88 - 84.34
52-Week Range	45.00 - 85.42
Beta	1.49
Analysts	Strong Buy
Price Target	80.00 (-3.61%)
Earnings Date	Nov 9, 2025

About RDNT

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Jul 1, 1986
• Employees: 9,000
• Stock Exchange: NASDAQ
• Ticker Symbol: RDNT
• Website: https://www.radnet.com

Financial Performance

In 2024, RadNet's revenue was $1.83 billion, an increase of 13.18% compared to the previous year's $1.62 billion. Earnings were $2.79 million, a decrease of -8.25%.

Analyst Summary

According to 5 analysts, the average rating for RDNT stock is "Strong Buy." The 12-month stock price target is $80.0, which is a decrease of -3.61% from the latest price.

Price Target

$80.0

(-3.61% downside)

Analyst Consensus: Strong Buy